. Author manuscript; available in PMC: 2019 Jan 6.

Published in final edited form as: Clin Infect Dis. 2018 Jan 6;66(2):206–212. doi: 10.1093/cid/cix784

Table 4.

2 × 2 table of results of comparative testing with the TES-AgEIA in each group of 249 and 250 randomly sampled sera found positive or negative, respectively, by Tc-CTL-1MBA.

		Tc-CTL-1MBA
		+	−

TES-AgEIA	+	208 74.3%^†	72 25.7%^†	280
	+	83.5%^‡	28.8%^‡	280

	−	41 18.7%^†	178 81.3%^†	219
	−	16.5%^‡	71.2%^‡	219

		249	250
		χ²=150 P<0.0001

^†

Percentage positive or negative by Tc-CTL-1MBA within a row specifying all positive or negative TES-AgEIA results.

^‡

Percentage positive or negative by TES-AgEIA within a column specifying all positive or negative Tc-CTL-1MBA results.